Editas Medicine Inc (EDIT) — Cash Flow-to-Debt Ratio
Editas Medicine Inc (EDIT) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of $-23.06 Million could theoretically repay 0% of its total liabilities ($144.93 Million) in one year. Explore EDIT long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Editas Medicine Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Editas Medicine Inc across 13 annual periods. Also explore Editas Medicine Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Editas Medicine Inc (2013–2025)
Year-by-year debt coverage analysis for Editas Medicine Inc. For market capitalisation and broader financial context, see market value of Editas Medicine Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.04x | $-165.24 Million | $159.25 Million | ▼ -2.3% |
| 2024 | -1.01x | $-210.28 Million | $207.31 Million | ▼ -15.2% |
| 2023 | -0.88x | $-132.18 Million | $150.06 Million | ▲ +23.7% |
| 2022 | -1.15x | $-177.35 Million | $153.64 Million | ▲ +12.7% |
| 2021 | -1.32x | $-163.80 Million | $123.84 Million | ▼ -31.7% |
| 2020 | -1.00x | $-179.84 Million | $179.02 Million | ▼ -508.8% |
| 2019 | -0.17x | $-40.67 Million | $246.45 Million | ▲ +33.5% |
| 2018 | -0.25x | $-45.71 Million | $184.22 Million | ▼ -335.2% |
| 2017 | -0.06x | $-9.42 Million | $165.18 Million | ▲ +89.2% |
| 2016 | -0.53x | $-49.93 Million | $94.58 Million | ▼ -2171.4% |
| 2015 | -0.02x | $-5.40 Million | $232.48 Million | ▲ +92.6% |
| 2014 | -0.31x | $-8.65 Million | $27.48 Million | ▲ +52.0% |
| 2013 | -0.66x | $-2.78 Million | $4.24 Million | — |